72
Participants
Start Date
June 30, 2015
Primary Completion Date
October 31, 2017
Study Completion Date
October 31, 2017
Aminolevulinic Acid
A 0,25mm-thick layer of BF-200 ALA (aminolevulinic acid, Ameluz®) light sensitizer gel is applied on one randomized treatment side of face.
Methyl 5-aminolevulinate
A 0,25mm-thick layer of MAL (methyl 5-aminolevulinate, Metvix®) light sensitizer cream is applied on one randomized treatment side of face.
Päijät-Häme Central Hospital, Lahti
Tampere University Hospital, Tampere
Vaasa Central Hospital, Vaasa
Päijänne Tavastia Central Hospital
OTHER
Tampere University Hospital
OTHER
Vaasa Central Hospital, Vaasa, Finland
OTHER
Tampere University
OTHER
STUK - Radiation and Nuclear Safety Authority: Finland
UNKNOWN
Joint Authority for Päijät-Häme Social and Health Care
OTHER